Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
France
/
Healthcare
/
Cegedim
CGM
Cegedim
Legacy Challenges Will Test Healthcare Digitalization As Modest Opportunities Open
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
18 Jul 25
Updated
24 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€11.00
2.3% undervalued
intrinsic discount
24 Jul
€10.75
Loading
1Y
-11.2%
7D
4.9%
Author's Valuation
€11.0
2.3% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€11.0
2.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-26m
792m
2014
2017
2020
2023
2025
2026
2028
Revenue €791.9m
Earnings €28.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.23%
Healthtech revenue growth rate
3.74%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.02%
Calculation
€28.38m
Earnings '28
x
7.48x
PE Ratio '28
=
€212.16m
Market Cap '28
€212.16m
Market Cap '28
/
13.72m
No. shares '28
=
€15.46
Share Price '28
€15.46
Share Price '28
Discounted to 2025 @ 12.02% p.a.
=
€11.00
Fair Value '25
